Structural development of liver X receptor (LXR) antagonists derived from thalidomide-related glucosidase inhibitors

T Noguchi-Yachide, H Miyachi, H Aoyama…

Index: Noguchi-Yachide, Tomomi; Miyachi, Hiroyuki; Aoyama, Hiroshi; Aoyama, Atsushi; Makishima, Makoto; Hashimoto, Yuichi Chemical and Pharmaceutical Bulletin, 2007 , vol. 55, # 12 p. 1750 - 1754

Full Text: HTML

Citation Number: 17

Abstract

Following our previous discovery of LXR antagonistic activity of 2′-substituted phenylphthalimides derived from thalidomide-related glucosidase inhibitors, structure– activity studies and further structural development led to 5-chloro-N-2′-n-pentylphenyl-1, 3- dithiophthalimide (5CPPSS-50), with IC 50 values of about 10 and 13 μM for LXRα and LXRβ, respectively.